Aligos Therapeutics, Inc. (ALGS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 92.13M |
| Enterprise Value | 79.07M |
| P/E Ratio | -0.4 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.52 |
| Price/Book Ratio | 2.38 |
| Enterprise/Revenue | -0.1 |
| Enterprise/EBITDA | 0.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -2.15 |
| Operating Margin | -2.36 |
| Return On Assets | -1.4 |
| Return On Equity | -2.06 |
| Revenue | 2.19M |
| Revenue/Share | 2.94 |
| Gross Profit | 1.26M |
| EBITDA | -22.95M |
| Net Income | -24.19M |
| Diluted EPS | -2.45 |
| Total Cash | 31.09M |
| Total Cash/Share | 2.97 |
| Total Debt | 11.9M |
| Total Debt/Equity | 1.05 |
| Current Ratio | 1.77 |
| Book Value Per Share | 1.08 |
| 52-Week Change | -62.7 |
| 52-Week High | 13.69 |
| 52-Week Low | 2.56 |
| Moving Average 50 Days | 5.25 |
| Moving Average 200 Days | 6.13 |
| Average Volume | 53,773 |
| Shares Outstanding | 6.24M |
| % Held by Institutions | 21.98 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 19, 2024 |